Sociedad Americana de Hirudoterapia

Rotator Cuff Tendinopathy

Investigational use for non-surgical rotator cuff tendinopathy and chronic shoulder impingement; case-series evidence for pain reduction.

Tier C — InvestigationalInvestigacionalLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Resumen para el Paciente

¿Está esto autorizado por FDA para este uso?
Not FDA-cleared for rotator-cuff tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for shoulder tendinopathy is investigational.
¿Qué evidencia existe?
Tier C (investigational). Small case series report shoulder pain-score and range-of-motion improvement after 2-4 sessions. There are no randomized controlled trials specific to rotator-cuff tendinopathy (the related Tier B entry for lateral-epicondylitis is the lone tendinopathy with RCT support). Evidence-based first-line care is structured physiotherapy and graded exercise; corticosteroid or platelet-rich plasma injections, subacromial decompression, or rotator-cuff repair are reserved for refractory or torn cases.
Riesgos principales
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the shoulder for 5 to 10 days
  • Itching and irritation at bite sites for days to weeks
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva (uncommon)
  • Temporary worsening of shoulder pain for 1 to 2 days after the session
  • Small permanent scars at bite sites
Quién no debería considerar esto
  • Patients on blood thinners (warfarin INR >2.0, DOACs, heparin)
  • Patients with hemophilia or other bleeding disorders
  • Patients with severe anemia (Hb <10 g/dL)
  • Patients with full-thickness rotator-cuff tear requiring surgical evaluation
  • Patients with acute septic arthritis or active joint infection
  • Patients with a recent corticosteroid injection within 4 weeks
  • Patients with a weakened immune system
Qué preguntar a su clínico
  • Have I been evaluated by orthopedics or sports medicine with imaging (ultrasound or MRI)?
  • Do I have a tendinopathy, partial tear, or full-thickness tear — and what is the right treatment for each?
  • Have I completed a structured physical-therapy program of at least 12 weeks?
  • What evidence supports leech therapy for rotator-cuff tendinopathy specifically?
  • What is the practitioner's experience and Aeromonas-prevention plan?
  • What is the realistic chance of benefit, and for how long?
  • What is the cost?
Cuándo buscar atención urgente
  • Sudden inability to lift the arm after trauma (possible acute tear)
  • Fever, hot swollen shoulder joint (possible septic arthritis)
  • Spreading redness, warmth, pus, or red streaks (cellulitis)
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

Qué NO significa esto

  • This is not FDA-cleared for rotator-cuff tendinopathy.
  • Small uncontrolled case series are not evidence of efficacy versus structured physiotherapy.
  • Mechanism rationale (local anti-inflammation) does NOT establish clinical efficacy.
  • Leech therapy does NOT repair tendon tears or address underlying biomechanics.
  • Leech therapy is not a substitute for orthopedic evaluation when a tear is suspected.

Clinical Profile

Category
musculoskeletal
ICD-10
M75.30, M75.31, M75.32, M75.100, M75.121
Safety tier
low

Evidence Summary

No controlled clinical trial or credible case series of leech therapy for rotator cuff tendinopathy has been published; there is no reliable evidence of reduction in VAS pain or improvement in SPADI scores. Any proposed local anti-inflammatory mechanism is speculative and unproven in this condition. Evidence-based care — a structured physiotherapy program (scapular stabilization and progressive rotator cuff strengthening), analgesia, and consideration of corticosteroid injection — remains first-line, and patients with full-thickness tears or a surgical indication should be referred for orthopedic evaluation. ASH position: any use of leech therapy for rotator cuff tendinopathy is investigational and mechanistic only.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Yildirim MA et al. (2016), n=24

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Full-thickness rotator cuff tear with surgical indication
  • Active calcific tendinopathy with severe acute pain (needle barbotage preferred)

Related Conditions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

Rotator Cuff Tendinopathy — Hirudotherapy Evidence | ASH